<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: FDA&#8217;s Job: Minimize Risks Through Education, Regulation and Enforcement</title>
	<atom:link href="http://axendia.com/blog/index.php/2009/06/09/fdas-job-minimize-risks-through-education-regulation-and-enforcement/feed/" rel="self" type="application/rss+xml" />
	<link>http://axendia.com/blog/2009/06/09/fdas-job-minimize-risks-through-education-regulation-and-enforcement/</link>
	<description>A Journal for Industry Executives</description>
	<pubDate>Wed, 23 May 2012 16:24:22 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Life-Science Panorama - A Journal for Industry Executives &#187; What to Expect from FDA in 2010</title>
		<link>http://axendia.com/blog/2009/06/09/fdas-job-minimize-risks-through-education-regulation-and-enforcement/comment-page-1/#comment-66</link>
		<dc:creator>Life-Science Panorama - A Journal for Industry Executives &#187; What to Expect from FDA in 2010</dc:creator>
		<pubDate>Tue, 15 Dec 2009 14:58:13 +0000</pubDate>
		<guid isPermaLink="false">http://axendia.com/blog/?p=174#comment-66</guid>
		<description>[...] The FDA&#8217;s role under President Obama is clear: &#8220;Minimize Risks Through Education, Regulation, and Enforcement.&#8221; (See report on the then newly appointed FDA Commissioner Margaret A. Hamburg, M.D., and FDA Principal Deputy Commissioner Joshua M. Sharfstein, M.D., and their vision for the Agency in June 9, 2009 article in Life-Science Panorama). [...]</description>
		<content:encoded><![CDATA[<p>[...] The FDA&#8217;s role under President Obama is clear: &#8220;Minimize Risks Through Education, Regulation, and Enforcement.&#8221; (See report on the then newly appointed FDA Commissioner Margaret A. Hamburg, M.D., and FDA Principal Deputy Commissioner Joshua M. Sharfstein, M.D., and their vision for the Agency in June 9, 2009 article in Life-Science Panorama). [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

